As of 2024-07-27, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is
-2.53 USD. This ALDX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 4.15 USD, the upside of Aldeyra Therapeutics Inc is
-160.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.53 USD
Intrinsic Value
ALDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.53 - -2.53 |
-2.53 |
-160.87% |
| P/E |
(7.22) - (13.93) |
(13.79) |
-432.3% |
| DDM - Stable |
(3.76) - (11.59) |
(7.68) |
-285.0% |
| DDM - Multi |
(4.17) - (10.32) |
(5.98) |
-244.1% |
ALDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
246.55 |
| Beta |
4.47 |
| Outstanding shares (mil) |
59.41 |
| Enterprise Value (mil) |
159.26 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.66% |
| Cost of Debt |
5.00% |
| WACC |
10.23% |